DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

Documenti analoghi

• Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1
  di: Lugthart, Sanne, et al.
  Pubblicazione: (2011)
• Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features
  di: Figueroa, Maria E., et al.
  Pubblicazione: (2009)
• Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
  di: Wouters, Bas J., et al.
  Pubblicazione: (2009)
• Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling
  di: Verhaak, Roel G.W., et al.
  Pubblicazione: (2009)
• A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects
  di: Wouters, Bas J., et al.
  Pubblicazione: (2009)